Correlation Between Bristol Myers and Arcturus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on Bristol Myers and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Arcturus Therapeutics.
Diversification Opportunities for Bristol Myers and Arcturus Therapeutics
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bristol and Arcturus is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Arcturus Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and Arcturus Therapeutics
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.5 times more return on investment than Arcturus Therapeutics. However, Bristol Myers Squibb is 2.01 times less risky than Arcturus Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Arcturus Therapeutics Holdings is currently generating about 0.04 per unit of risk. If you would invest 5,432 in Bristol Myers Squibb on September 2, 2024 and sell it today you would earn a total of 490.00 from holding Bristol Myers Squibb or generate 9.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Arcturus Therapeutics Holdings
Performance |
| Timeline |
| Bristol Myers Squibb |
| Arcturus Therapeutics |
Bristol Myers and Arcturus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Arcturus Therapeutics
The main advantage of trading using opposite Bristol Myers and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.| Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
| Arcturus Therapeutics vs. 89bio Inc | Arcturus Therapeutics vs. Madrigal Pharmaceuticals | Arcturus Therapeutics vs. Pliant Therapeutics | Arcturus Therapeutics vs. Arcellx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |